Zobrazeno 1 - 10
of 291
pro vyhledávání: '"Ralph Wäsch"'
Autor:
Miriam Mozaffari Jovein, Gabriele Ihorst, Jesús Duque-Afonso, Ralph Wäsch, Hartmut Bertz, Claudia Wehr, Justus Duyster, Robert Zeiser, Jürgen Finke, Florian Scherer
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Primary induction failure (PIF) in acute myeloid leukemia (AML) patients is associated with poor outcome, with allogeneic hematopoietic stem cell transplantation (HCT) being the sole curative therapeutic option. Here, we retrospectively eval
Externí odkaz:
https://doaj.org/article/b0c4ddf6437348259a83d0ec04d80321
Publikováno v:
Cancers, Vol 16, Iss 11, p 1987 (2024)
Recently, CD19-directed chimeric antigen receptor (CAR) T-cell therapies have revolutionized treatment strategies for diffuse large B-cell lymphoma (DLBCL). CAR T-cell therapy is increasingly used as a second-line therapy for patients with DLBCL with
Externí odkaz:
https://doaj.org/article/5f320a8d96864e279bca232e1a3e1fdd
Autor:
Katja Schoeller, Gabriele Ihorst, Heike Reinhardt, Maximilian Holler, Sophia Scheubeck, Georg Herget, Ralph Wäsch, Monika Engelhardt
Publikováno v:
Haematologica, Vol 109, Iss 4 (2023)
Externí odkaz:
https://doaj.org/article/8993531c062348df89c07529a7bc32da
Autor:
Ralph Wäsch, Monika Engelhardt
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
Externí odkaz:
https://doaj.org/article/6e53a294b5404a95b5f5c764dba23b22
Autor:
Sina Wenger, Milena Pantic, Gabriele Ihorst, Stepan Cysar, Marc-Antoine Calba, Christine Greil, Ralph Wäsch, Monika Engelhardt
Publikováno v:
Haematologica, Vol 109, Iss 1 (2023)
Externí odkaz:
https://doaj.org/article/25e499aa263641d490fda66d7bb68456
Autor:
Nizar J Bahlis, Katja Weisel, Maria-Victoria Mateos, Hartmut Goldschmidt, Tom Martin, Daniel Morillo, Donna Reece, Paula Rodríguez-Otero, Manisha Bhutani, Anita D’souza, Albert Oriol, Laura Rosiñol Dachs, Bhagirathbhai Dholaria, Kalpana Bakshi, Lijuan Kang, Lien Vandenberk, Damiette Smit, Ralph Wäsch, Niels W.C.J. van de Donk, Ajai Chari
Publikováno v:
HemaSphere, Vol 7, p e90062ca (2023)
Externí odkaz:
https://doaj.org/article/2bcd2dcc8c5c44adb5296cd4eb1544f2
Autor:
Verena I. Gaidzik, Peter Paschka, Richard F. Schlenk, Daniela Weber, Stefan Fröhling, Alwin Krämer, Ralph Wäsch, Jörg Westermann, Karin Mayer, Maike de Wit, Walter Fiedler, Axel Benner, Michael Heuser, Felicitas Thol, Konstanze Döhner, Arnold Ganser, Hartmut Döhner
Publikováno v:
HemaSphere, Vol 7, Iss 5, p e877 (2023)
Externí odkaz:
https://doaj.org/article/4404753769fb4869903fee2cffeca2b3
Autor:
Nicola Gökbuget, Kristina Ihrig, Michael Stadler, Matthias Stelljes, Ahmet Elmaagacli, Michael Starck, Simon Raffel, Andrea Stoltefuss, Andreas Viardot, Karl-Anton Kreuzer, Daniela Heidenreich, Andrea Renzelmann, Ralph Wäsch, Max S. Topp, Barbara Ritter, Peter Reimer, Joachim Beck, Jörg Westermann, Knut Wendelin, Nael Alakel, Maher Hanoun, Hubert Serve, Dieter Hoelzer
Publikováno v:
Haematologica, Vol 108, Iss 7 (2023)
Cure rates in adult acute lymphoblastic leukemia (ALL) improved using pediatric-based chemotherapy and stem cell transplantation (SCT). However, limited data on the health condition of cured adults are available whereas pediatric data cannot be trans
Externí odkaz:
https://doaj.org/article/1d8dab2a15d6455985acc8405cfa5220
Autor:
Christoph Rummelt, Olga Grishina, Claudia Schmoor, Martina Crysandt, Michael Heuser, Katharina S. Götze, Richard F. Schlenk, Konstanze Döhner, Helmut R. Salih, Gerhard Heil, Carsten Müller-Tidow, Wolfram Brugger, Andrea Kündgen, Maike de Wit, Aristoteles Giagounidis, Sebastian Scholl, Andreas Neubauer, Jürgen Krauter, Gesine Bug, Haifa Kathrin Al-Ali, Ralph Wäsch, Heiko Becker, Annette M. May, Justus Duyster, Björn Hackanson, Arnold Ganser, Hartmut Döhner, Michael Lübbert
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
Externí odkaz:
https://doaj.org/article/3448ad0c720c4bd583057eb97a440fb5
Autor:
Maximilian Holler, Gabriele Ihorst, Heike Reinhardt, Amelie Rösner, Magdalena Braun, Mandy-Deborah Möller, Esther Dreyling, Katja Schoeller, Sophia Scheubeck, Ralph Wäsch, Monika Engelhardt
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
In heterogeneous multiple myeloma (MM) patients treatment decisions are challenging. The hypothesis was that adaptation of treatment intensity (dose reduction [DR] vs. none) according to an objective risk score (revised-myeloma comorbidity index [R-M
Externí odkaz:
https://doaj.org/article/d80ab32d31d348d9a3496168ea85d377